PDCD11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.170000E-01
Normal-vs-Stage2
4.307200E-01
Normal-vs-Stage3
2.569800E-01
Normal-vs-Stage4
7.716000E-01
Stage1-vs-Stage2
7.161000E-01
Stage1-vs-Stage3
2.343200E-01
Stage1-vs-Stage4
8.859400E-01
Stage2-vs-Stage3
2.620600E-01
Stage2-vs-Stage4
6.516600E-01
Stage3-vs-Stage4
3.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.030600E-01
Normal-vs-AfricanAmerican
7.400400E-01
Normal-vs-Asian
2.246600E-01
Caucasian-vs-AfricanAmerican
5.917000E-01
Caucasian-vs-Asian
7.747800E-01
AfricanAmerican-vs-Asian
4.532800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.705000E-01
Normal-vs-Female
3.315800E-01
Male-vs-Female
3.789200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.092400E-01
Normal-vs-Age(41-60Yrs)
4.791200E-01
Normal-vs-Age(61-80Yrs)
3.491200E-01
Normal-vs-Age(81-100Yrs)
6.250600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.394000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.486400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.215400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.646200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.708400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.430600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.699200E-01
Normal-vs-Daily Drinker
5.690600E-01
Normal-vs-Weekly Drinker
5.684400E-01
Normal-vs-Occasional Drinker
5.700200E-01
Normal-vs-Social Drinker
3.789000E-01
Non Drinker-vs-Daily Drinker
6.320600E-01
Non Drinker-vs-Weekly Drinker
3.521800E-01
Non Drinker-vs-Occasional Drinker
2.903800E-01
Non Drinker-vs-Social Drinker
7.258600E-01
Daily Drinker-vs-Weekly Drinker
6.981800E-01
Daily Drinker-vs-Occasional Drinker
6.330200E-01
Daily Drinker-vs-Social Drinker
9.026800E-01
Weekly Drinker-vs-Occasional Drinker
9.728400E-01
Weekly Drinker-vs-Social Drinker
5.184800E-01
Occasional Drinker-vs-Social Drinker
4.711400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.622600E-01
Normal-vs-Grade 2
7.820600E-01
Normal-vs-Grade 3
6.918600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.997990E-01
Grade 1-vs-Grade 3
1.804360E-02
Grade 1-vs-Grade 4
6.622600E-01
Grade 2-vs-Grade 3
7.054500E-02
Grade 2-vs-Grade 4
7.820600E-01
Grade 3-vs-Grade 4
6.918600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.413600E-01
Normal-vs-NonDiabetic
3.168600E-01
Diabetic-vs-NonDiabetic
6.609800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.676000E-01
Normal-vs-NoPancreatitis
3.403200E-01
Pancreatitis-vs-NoPancreatitis
1.216770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.710600E-01
Normal-vs-N1
4.305000E-01
N0-vs-N1
8.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.022600E-01
Normal-vs-TP53-NonMutant
5.536000E-01
TP53-Mutant-vs-TP53-NonMutant
1.028400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
